Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1996Molecular and Cellular BiologyOpen Access

A Dominant Inhibitory Mutant of the Type II Transforming Growth Factor β Receptor in the Malignant Progression of a Cutaneous T-Cell Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

PKPetra KnausBerlin-Brandenburger Centrum für Regenerative TherapienDLDirk LindemannUniversity Hospital Carl Gustav CarusJDJohn F. DeCoteauUniversity of Saskatchewan

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Knaus et al. (1996) studied this question.

synapsesocial.com/papers/6a9d00b664bf10ef437bf413https://doi.org/10.1128/mcb.16.7.3480
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability1995 · 2,284 citations
  2. 2Absence of TGF-β Receptors and Growth Inhibitory Responses in Retinoblastoma Cells1988 · 321 citations
  3. 3Inhibition of PDGF β Receptor Signal Transduction by Coexpression of a Truncated Receptor1991 · 170 citations
  4. 4A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain1993 · 133 citations